AMMONIA N 13

Post-LOE

ammonia n-13

IONETIX
ANDAINTRAVENOUSINJECTABLE
Approved
Dec 2018
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

Radiopharmaceutical Activity

Pharmacologic Class:

Radioactive Diagnostic Agent

Company
IONETIX
IONETIX
MI - Lansing
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers